A phase II study of the combination of BKM120 (buparlisib) and bevacizumab in patients with relapsed/refractory glioblastoma multiforme (GBM). Meeting Abstract

cited authors

  • Shih, Kent C., Chowdhary, Sajeel A., Becker, Kevin P., Baehring, Joachim M., Liggett, William H., Burris, Howard A., Hainsworth, John D.

Publication Date

  • May 20, 2015

webpage

published in

category

volume

  • 33

issue

  • 15

WoS Citations

  • 2

WoS References

  • 0